4//SEC Filing
Ludwig Dale L. 4
Accession 0001213900-20-022314
CIK 0001388320other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:03 PM ET
Size
5.6 KB
Accession
0001213900-20-022314
Insider Transaction Report
Form 4
Ludwig Dale L.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-12+50,000→ 50,000 totalExercise: $9.55Exp: 2030-08-12→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant.
- [F2]Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001727406
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:03 PM ET
- Size
- 5.6 KB